Zentalis Pharmaceuticals, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Zentalis Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • Zentalis Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -35.6 %, a 32% increase year-over-year.
  • Zentalis Pharmaceuticals, Inc. annual Return On Assets for 2023 was -52 %, a 12.1% decline from 2022.
  • Zentalis Pharmaceuticals, Inc. annual Return On Assets for 2022 was -46.4 %, a 9.72% decline from 2021.
  • Zentalis Pharmaceuticals, Inc. annual Return On Assets for 2021 was -42.3 %, a 1.03% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -52 -5.6 -12.1% Jan 1, 2023 Dec 31, 2023
2022 -46.4 -4.11 -9.72% Jan 1, 2022 Dec 31, 2022
2021 -42.3 +0.44 +1.03% Jan 1, 2021 Dec 31, 2021
2020 -42.7 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.